These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 24851067

  • 1. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
    Kim WG, Kim TY, Kim TH, Jang HW, Jo YS, Park YJ, Kim SW, Kim WB, Shong M, Park DJ, Chung JH, Shong YK, Cho BY.
    Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067
    [Abstract] [Full Text] [Related]

  • 2. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M, Niederle B.
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [Abstract] [Full Text] [Related]

  • 3. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma.
    Ernaga Lorea A, Migueliz Bermejo I, Anda Apiñániz E, Pineda Arribas J, Toni García M, Martínez de Esteban JP, Insausti Serrano AM.
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.
    Cancer; 2003 Mar 01; 97(5):1186-94. PubMed ID: 12599224
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
    Wenter V, Albert NL, Unterrainer M, Ahmaddy F, Ilhan H, Jellinek A, Knösel T, Bartenstein P, Spitzweg C, Lehner S, Todica A.
    Eur J Nucl Med Mol Imaging; 2021 Feb 01; 48(2):449-460. PubMed ID: 32683470
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.
    Bhargav PR, Mishra A, Agarwal G, Agarwal A, Pradhan PK, Gambhir S, Verma AK, Mishra SK.
    World J Surg; 2010 Jan 01; 34(1):40-7. PubMed ID: 20020292
    [Abstract] [Full Text] [Related]

  • 7. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
    Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K.
    Ann Surg Oncol; 2013 Sep 01; 20(9):2944-50. PubMed ID: 23616135
    [Abstract] [Full Text] [Related]

  • 8. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
    Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K.
    Thyroid; 2012 Aug 01; 22(8):798-804. PubMed ID: 22853727
    [Abstract] [Full Text] [Related]

  • 9. Importance of lymph node metastases in follicular thyroid cancer.
    Witte J, Goretzki PE, Dieken J, Simon D, Röher HD.
    World J Surg; 2002 Aug 01; 26(8):1017-22. PubMed ID: 12045860
    [Abstract] [Full Text] [Related]

  • 10. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY, Chan WF, Lam KY, Wan KY.
    Ann Surg; 2005 Nov 01; 242(5):708-15. PubMed ID: 16244545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
    Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H.
    Cancer; 2003 Aug 15; 98(4):712-9. PubMed ID: 12910514
    [Abstract] [Full Text] [Related]

  • 14. Follicular thyroid carcinoma: histology and prognosis.
    D'Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH.
    Cancer; 2004 Mar 15; 100(6):1123-9. PubMed ID: 15022277
    [Abstract] [Full Text] [Related]

  • 15. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
    Jin M, Kim ES, Kim BH, Kim HK, Yi HS, Jeon MJ, Kim TY, Kang HC, Kim WB, Shong YK, Kim M, Kim WG.
    Endocrinol Metab (Seoul); 2020 Sep 15; 35(3):618-627. PubMed ID: 32981304
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis.
    Zhang T, He L, Wang Z, Dong W, Sun W, Zhang P, Zhang H.
    Endocrine; 2023 Dec 15; 82(3):457-466. PubMed ID: 37804444
    [Abstract] [Full Text] [Related]

  • 19. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N, Kulak H, Tokmak E, Tar P, Ibiş E, Aras G.
    Nucl Med Commun; 2006 Apr 15; 27(4):377-9. PubMed ID: 16531925
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
    Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zettinig G, Niederle B.
    Endocr Relat Cancer; 2004 Mar 15; 11(1):131-9. PubMed ID: 15027890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.